Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IgG Antibodies After SARS-CoV-2 mRNA Vaccine in Kidney Transplantation

NCT04832841 is registered in ClinicalTrials.gov with Institute for Clinical and Experimental Medicine as lead sponsor.

NCT NCT04832841
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04832841 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IgG Antibodies After SARS-CoV-2 mRNA Vaccine in Kidney Transplantation
Lead sponsor
Institute for Clinical and Experimental Medicine
Phase
Observational
Overall status
Completed
Start date
March 18, 2021
Completion date
March 30, 2022
Enrollment
753 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplantation